| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL22A1 FBN1 HMCN2 HSPG2 COL9A2 PAPLN VWA1 EMILIN1 HMCN1 VWA5A MUC2 MUC6 FBN3 | 4.26e-08 | 188 | 195 | 13 | GO:0005201 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 8.18e-06 | 14 | 195 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.75e-05 | 23 | 195 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | calcium ion binding | TPO PADI4 CDHR2 ITGA5 ADAM8 LRP1B FBN1 HMCN2 PCDH11X PITPNM2 HSPG2 STAB2 ESYT1 PCDH11Y SELENON HMCN1 DCHS1 ATP2A1 FBN3 | 1.43e-04 | 749 | 195 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | filamin binding | 1.73e-04 | 29 | 195 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.73e-04 | 29 | 195 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 3.25e-04 | 34 | 195 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.68e-04 | 16 | 195 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL22A1 FBN1 HMCN2 DLG3 HSPG2 COL9A2 ANK1 PAPLN VWA1 EMILIN1 HMCN1 VWA5A TLN1 MUC2 RPL4 MUC6 KRT36 FBN3 MYBPC2 MYBPC3 | 4.71e-04 | 891 | 195 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 5.64e-04 | 17 | 195 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 5.64e-04 | 17 | 195 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 6.11e-04 | 70 | 195 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 7.40e-04 | 73 | 195 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.07e-03 | 21 | 195 | 3 | GO:0030228 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDCD1 CEACAM5 PSG1 PSG3 CDHR2 ITGA1 BCL6 ITGA5 ADAM8 HMCN2 PTPRD PTPRF PTPRS GLI3 PCDH11X DLG3 PSG8 SEMA4D PCDH11Y CR1 EMILIN1 NDFIP1 TBX18 HMCN1 TLN1 DCHS1 TRPV4 DUSP10 SIGLEC1 | 3.13e-07 | 1077 | 194 | 29 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.14e-06 | 83 | 194 | 8 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.26e-06 | 21 | 194 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.26e-06 | 21 | 194 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PSG1 PSG3 CDHR2 HMCN2 PTPRF PCDH11X PSG8 PCDH11Y HMCN1 DCHS1 | 1.65e-06 | 187 | 194 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PSG1 PSG3 CDHR2 ITGA5 HMCN2 PTPRD PTPRF PTPRS PCDH11X PSG8 PCDH11Y HMCN1 DCHS1 | 1.68e-06 | 313 | 194 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 3.47e-06 | 96 | 194 | 8 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.91e-06 | 29 | 194 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 7.06e-06 | 14 | 194 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 9.55e-06 | 15 | 194 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 9.55e-06 | 15 | 194 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.55e-06 | 15 | 194 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 9.55e-06 | 15 | 194 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.26e-05 | 16 | 194 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 1.45e-05 | 192 | 194 | 10 | GO:1903038 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.64e-05 | 17 | 194 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.64e-05 | 17 | 194 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.64e-05 | 17 | 194 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.09e-05 | 18 | 194 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 2.34e-05 | 162 | 194 | 9 | GO:0030316 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.73e-05 | 38 | 194 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 2.80e-05 | 93 | 194 | 7 | GO:1901184 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | PDCD1 CEACAM5 PSG1 PSG3 BCL6 ADAM8 GLI3 PSG8 CR1 NDFIP1 TRPV4 | 2.80e-05 | 252 | 194 | 11 | GO:0022408 |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 2.84e-05 | 166 | 194 | 9 | GO:0002698 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | CEACAM5 PSG1 PSG3 BRINP1 BCL6 FBN1 PTPRS GLI3 PITX3 PSG8 RTN4 CR1 DUSP10 | 3.15e-05 | 353 | 194 | 13 | GO:0010721 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.27e-05 | 20 | 194 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 3.59e-05 | 171 | 194 | 9 | GO:0050868 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.01e-05 | 21 | 194 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.48e-05 | 42 | 194 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.86e-05 | 22 | 194 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.84e-05 | 23 | 194 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.84e-05 | 23 | 194 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | PDCD1 CEACAM5 PSG1 PSG3 BCL6 ADAM8 GLI3 PSG8 SEMA4D HSPG2 CR1 NDFIP1 TRPV4 | 5.86e-05 | 375 | 194 | 13 | GO:0007162 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | CEACAM5 DHRS3 PSG1 PSG3 TCIRG1 AHDC1 CHUK NEDD4 ALMS1 GLI3 PITX3 ARID5B PSG8 STRC STRCP1 FOXE1 HSPG2 RTN4 APC RBM20 TBX18 BTBD7 TLE1 TLE3 DCHS1 TRPV4 MYBPC3 | 5.98e-05 | 1269 | 194 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | PDCD1 CEACAM5 PSG1 PSG3 ADGRB2 C5AR2 BRINP1 BCL6 FBN1 ALMS1 PTPRS GLI3 PITX3 PSG8 NAXE NOVA2 HSPG2 UTS2R RTN4 APC CR1 EMILIN1 RGS4 NDFIP1 OPRM1 LNPEP TLE3 DUSP10 SIGLEC1 ATP2A1 | 6.01e-05 | 1488 | 194 | 30 | GO:0051241 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 6.96e-05 | 24 | 194 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.96e-05 | 24 | 194 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 6.96e-05 | 24 | 194 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 7.01e-05 | 46 | 194 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 7.01e-05 | 46 | 194 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 8.22e-05 | 25 | 194 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 8.22e-05 | 25 | 194 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | circulatory system development | PCSK5 CEACAM5 DHRS3 PSG1 PSG3 ADGRB2 ITGA5 ADAM8 NEDD4 FBN1 PTPRB GLI3 PSG8 NAXE MGRN1 HSPG2 MEF2B UTS2R STAB2 RTN4 APC TFAP2B EMILIN1 RGS4 RBM20 TBX18 VWA5A DCHS1 MYBPC3 | 8.46e-05 | 1442 | 194 | 29 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 9.35e-05 | 151 | 194 | 8 | GO:1902106 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 9.53e-05 | 49 | 194 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 9.53e-05 | 49 | 194 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.05e-04 | 50 | 194 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.12e-04 | 27 | 194 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.15e-04 | 116 | 194 | 7 | GO:0045670 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.27e-04 | 52 | 194 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.30e-04 | 28 | 194 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 1.34e-04 | 159 | 194 | 8 | GO:1903707 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.39e-04 | 53 | 194 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | CEACAM5 PSG1 PSG3 SREBF1 SOCS7 CHUK FBN1 PTPRF PSG8 CPEB2 TCF12 APC TRPV4 ATP2A1 PCK2 | 1.55e-04 | 530 | 194 | 15 | GO:0043434 |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.61e-04 | 86 | 194 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.74e-04 | 124 | 194 | 7 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 1.80e-04 | 211 | 194 | 9 | GO:0051250 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.81e-04 | 56 | 194 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.92e-04 | 126 | 194 | 7 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.96e-04 | 31 | 194 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of cell activation | 2.08e-04 | 264 | 194 | 10 | GO:0050866 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.22e-04 | 32 | 194 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.22e-04 | 32 | 194 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.22e-04 | 32 | 194 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.32e-04 | 59 | 194 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | PCSK5 ITGA1 BCL6 ITGA5 ADAM8 STRC STRCP1 EMILIN1 TLN1 SIGLEC1 | 2.49e-04 | 270 | 194 | 10 | GO:0007160 |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.51e-04 | 33 | 194 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.51e-04 | 33 | 194 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 2.57e-04 | 271 | 194 | 10 | GO:0032869 | |
| GeneOntologyBiologicalProcess | negative regulation of isotype switching to IgE isotypes | 2.62e-04 | 3 | 194 | 2 | GO:0048294 | |
| GeneOntologyBiologicalProcess | negative regulation of plasma cell differentiation | 2.62e-04 | 3 | 194 | 2 | GO:1900099 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 2.78e-04 | 95 | 194 | 6 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 2.80e-04 | 134 | 194 | 7 | GO:0070664 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.82e-04 | 34 | 194 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.82e-04 | 34 | 194 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 2.82e-04 | 34 | 194 | 4 | GO:0035335 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 3.16e-04 | 63 | 194 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 3.16e-04 | 35 | 194 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 3.36e-04 | 182 | 194 | 8 | GO:0002761 | |
| GeneOntologyBiologicalProcess | bone resorption | 3.48e-04 | 99 | 194 | 6 | GO:0045453 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.92e-04 | 66 | 194 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | response to insulin | CEACAM5 PSG1 PSG3 SREBF1 SOCS7 PTPRF PSG8 CPEB2 APC TRPV4 PCK2 | 4.12e-04 | 342 | 194 | 11 | GO:0032868 |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 4.19e-04 | 16 | 194 | 3 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 4.19e-04 | 16 | 194 | 3 | GO:0002713 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 4.50e-04 | 239 | 194 | 9 | GO:0050777 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | 4.64e-04 | 240 | 194 | 9 | GO:0002695 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.82e-04 | 39 | 194 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PCSK5 PDCD1 CEACAM5 PSG1 PSG3 BCL6 ITGA5 ADAM8 GLI3 PSG8 SEMA4D HSPG2 APC CR1 EMILIN1 NDFIP1 TBX18 TLN1 TRPV4 DUSP10 | 4.83e-04 | 927 | 194 | 20 | GO:0030155 |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | PDCD1 CEACAM5 PSG1 PSG3 ADGRB2 BRINP1 BCL6 FBN1 ALMS1 PTPRS GLI3 PITX3 PSG8 NAXE SEMA4D HSPG2 RTN4 APC CR1 EMILIN1 RGS4 NDFIP1 TRPV4 DUSP10 | 5.00e-04 | 1220 | 194 | 24 | GO:0051093 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.16e-04 | 70 | 194 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of isotype switching | 5.22e-04 | 4 | 194 | 2 | GO:0045829 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 5.27e-04 | 107 | 194 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.32e-04 | 40 | 194 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 5.51e-04 | 71 | 194 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 5.51e-04 | 71 | 194 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 5.77e-04 | 151 | 194 | 7 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.85e-04 | 41 | 194 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | TANC2 CEACAM5 PSG1 PSG3 ADGRB2 BCL6 ITGA5 NEDD4 PHLDB1 PTPRD PTPRF PTPRS PSG8 NAXE SEMA4D HSPG2 UTS2R RTN4 APC EMILIN1 BTBD7 RPL4 | 6.18e-04 | 1090 | 194 | 22 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 6.26e-04 | 73 | 194 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of cell development | CEACAM5 PSG1 PSG3 BRINP1 BCL6 ADAM8 FBN1 PTPRD PTPRF PTPRS GLI3 HES7 PITX3 PSG8 SEMA4D RTN4 APC CR1 NDFIP1 OPRM1 DUSP10 RPL4 | 6.57e-04 | 1095 | 194 | 22 | GO:0060284 |
| GeneOntologyCellularComponent | A band | 9.21e-06 | 52 | 197 | 6 | GO:0031672 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.27e-05 | 16 | 197 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | TRAV12-3 CEACAM5 PSG1 PSG3 ITGA1 ITGA5 CHUK DLG3 PSG8 GRIK5 EMILIN1 TRBV6-3 TRAV21 | 2.95e-05 | 350 | 197 | 13 | GO:0098802 |
| GeneOntologyCellularComponent | receptor complex | TRAV12-3 CEACAM5 PSG1 PSG3 ITGA1 ITGA5 LRP1B CHUK PTPRB DLG3 PSG8 SEMA4D GRIK5 CR1 EMILIN1 TRBV6-3 TRAV21 | 3.83e-05 | 581 | 197 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | stereocilium tip | 4.90e-05 | 22 | 197 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | external encapsulating structure | LINGO3 COL22A1 FBN1 FCGBP HMCN2 HSPG2 COL9A2 PAPLN VWA1 CPN2 PKHD1L1 EMILIN1 HMCN1 VWA5A MUC2 MUC6 FBN3 | 1.74e-04 | 658 | 197 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | adherens junction | 1.89e-04 | 212 | 197 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | extracellular matrix | LINGO3 COL22A1 FBN1 FCGBP HMCN2 HSPG2 COL9A2 PAPLN VWA1 CPN2 EMILIN1 HMCN1 VWA5A MUC2 MUC6 FBN3 | 5.07e-04 | 656 | 197 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.36e-04 | 157 | 197 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | cell projection membrane | CEACAM5 DHRS3 PSG1 PSG3 CDHR2 ITGA5 PSG8 ANK1 APC OPRM1 TLN1 TRPV4 | 8.34e-04 | 431 | 197 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | cilium | ABCA4 CEACAM5 DHRS3 PSG1 PSG3 KCNU1 ALMS1 GLI3 PCDH11X PSG8 STRC NAXE STRCP1 DNAH10 RTTN PCDH11Y TTLL4 TRPV4 CFAP46 | 8.70e-04 | 898 | 197 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | membrane protein complex | TRAV12-3 CEACAM5 PSG1 PSG3 SREBF2 BEST3 TCIRG1 ITGA1 ITGA5 ADAM8 SOCS7 CHUK KCNU1 DLG3 PSG8 HSPG2 ANK1 APC KCNK16 GRIK5 EMILIN1 SEC24C AP5B1 TRBV6-3 DCHS1 ATP2A1 TRAV21 | 8.76e-04 | 1498 | 197 | 27 | GO:0098796 |
| GeneOntologyCellularComponent | T cell receptor complex | 9.17e-04 | 163 | 197 | 7 | GO:0042101 | |
| GeneOntologyCellularComponent | basement membrane | 1.06e-03 | 122 | 197 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.17e-03 | 170 | 197 | 7 | GO:1902911 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | TRAV12-3 CEACAM5 PSG1 PSG3 ITGA1 ITGA5 ADAM8 CHUK DLG3 PSG8 HSPG2 APC GRIK5 EMILIN1 TRBV6-3 DCHS1 TRAV21 | 1.27e-03 | 785 | 197 | 17 | GO:0098797 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.34e-03 | 335 | 197 | 10 | GO:0061695 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.62e-03 | 90 | 197 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.36e-03 | 98 | 197 | 5 | GO:0060170 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.35e-06 | 35 | 158 | 6 | MP:0031618 | |
| MousePheno | decreased muscle cell glucose uptake | 4.54e-06 | 39 | 158 | 6 | MP:0030022 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.39e-05 | 47 | 158 | 6 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 2.81e-05 | 53 | 158 | 6 | MP:0003926 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.33e-05 | 17 | 158 | 4 | MP:0031047 | |
| MousePheno | abnormal muscle triglyceride level | 4.92e-05 | 36 | 158 | 5 | MP:0031412 | |
| MousePheno | increased skeletal muscle triglyceride level | 8.09e-05 | 21 | 158 | 4 | MP:0031415 | |
| MousePheno | increased insulin secretion | 8.27e-05 | 64 | 158 | 6 | MP:0003058 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.07e-04 | 67 | 158 | 6 | MP:0004130 | |
| MousePheno | decreased fatty acid oxidation | 1.40e-04 | 24 | 158 | 4 | MP:0014172 | |
| Domain | IGc2 | CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 2.65e-09 | 235 | 191 | 16 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 2.65e-09 | 235 | 191 | 16 | IPR003598 |
| Domain | VWF_A | COL22A1 ITGA1 HMCN2 ANAPC1 VWA1 SEC24C HMCN1 VWA5A CPNE4 CPNE7 | 7.00e-08 | 99 | 191 | 10 | IPR002035 |
| Domain | Ig_I-set | CEACAM5 LINGO3 HMCN2 PTPRD PTPRF PTPRS HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 6.15e-07 | 190 | 191 | 12 | IPR013098 |
| Domain | I-set | CEACAM5 LINGO3 HMCN2 PTPRD PTPRF PTPRS HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 6.15e-07 | 190 | 191 | 12 | PF07679 |
| Domain | IG | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 1.63e-06 | 421 | 191 | 17 | SM00409 |
| Domain | Ig_sub | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 1.63e-06 | 421 | 191 | 17 | IPR003599 |
| Domain | VWFA | 1.93e-06 | 82 | 191 | 8 | PS50234 | |
| Domain | VWA | 2.32e-06 | 84 | 191 | 8 | SM00327 | |
| Domain | EGF | TPO PCSK5 ADAM8 LRP1B VWDE FBN1 FCGBP HSPG2 STAB2 HMCN1 BRINP2 FBN3 | 5.67e-06 | 235 | 191 | 12 | SM00181 |
| Domain | EGF-like_dom | TPO PCSK5 ADAM8 LRP1B VWDE FBN1 FCGBP HMCN2 HSPG2 STAB2 HMCN1 FBN3 | 1.02e-05 | 249 | 191 | 12 | IPR000742 |
| Domain | - | 1.06e-05 | 74 | 191 | 7 | 3.40.50.410 | |
| Domain | Ig-like_fold | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 PTPRB HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN VWA1 PKHD1L1 HMCN1 SIGLEC1 LRRN4 MYBPC2 MYBPC3 | 1.19e-05 | 706 | 191 | 21 | IPR013783 |
| Domain | IG_LIKE | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 1.25e-05 | 491 | 191 | 17 | PS50835 |
| Domain | - | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 PTPRB PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN VWA1 PKHD1L1 HMCN1 SIGLEC1 LRRN4 MYBPC2 MYBPC3 | 1.59e-05 | 663 | 191 | 20 | 2.60.40.10 |
| Domain | Ig-like_dom | PDCD1 CEACAM5 PSG1 PSG3 LINGO3 HMCN2 PTPRD PTPRF PTPRS PSG8 SEMA4D HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 1.70e-05 | 503 | 191 | 17 | IPR007110 |
| Domain | VWF_type-D | 1.75e-05 | 16 | 191 | 4 | IPR001846 | |
| Domain | VWFD | 1.75e-05 | 16 | 191 | 4 | PS51233 | |
| Domain | VWD | 1.75e-05 | 16 | 191 | 4 | SM00216 | |
| Domain | VWD | 1.75e-05 | 16 | 191 | 4 | PF00094 | |
| Domain | ig | CEACAM5 PSG1 PSG3 PTPRD PTPRS PSG8 SEMA4D HSPG2 HMCN1 SIGLEC1 | 2.67e-05 | 190 | 191 | 10 | PF00047 |
| Domain | Immunoglobulin | CEACAM5 PSG1 PSG3 PTPRD PTPRS PSG8 SEMA4D HSPG2 HMCN1 SIGLEC1 | 2.67e-05 | 190 | 191 | 10 | IPR013151 |
| Domain | EGF_CA | 3.68e-05 | 122 | 191 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.14e-05 | 124 | 191 | 8 | IPR001881 | |
| Domain | Ig_2 | 1.02e-04 | 73 | 191 | 6 | PF13895 | |
| Domain | cEGF | 1.33e-04 | 26 | 191 | 4 | PF12662 | |
| Domain | cEGF | 1.33e-04 | 26 | 191 | 4 | IPR026823 | |
| Domain | EGF_3 | 1.58e-04 | 235 | 191 | 10 | PS50026 | |
| Domain | Growth_fac_rcpt_ | 2.06e-04 | 156 | 191 | 8 | IPR009030 | |
| Domain | Ig_V-set | 2.15e-04 | 199 | 191 | 9 | IPR013106 | |
| Domain | C8 | 2.16e-04 | 12 | 191 | 3 | PF08742 | |
| Domain | TIL | 2.16e-04 | 12 | 191 | 3 | PF01826 | |
| Domain | EGF_CA | 2.52e-04 | 86 | 191 | 6 | PF07645 | |
| Domain | fn3 | 2.67e-04 | 162 | 191 | 8 | PF00041 | |
| Domain | Unchr_dom_Cys-rich | 2.79e-04 | 13 | 191 | 3 | IPR014853 | |
| Domain | C8 | 2.79e-04 | 13 | 191 | 3 | SM00832 | |
| Domain | EGF_1 | 3.05e-04 | 255 | 191 | 10 | PS00022 | |
| Domain | BRINP | 3.10e-04 | 3 | 191 | 2 | IPR033237 | |
| Domain | FBN | 3.10e-04 | 3 | 191 | 2 | IPR011398 | |
| Domain | TIL_dom | 3.53e-04 | 14 | 191 | 3 | IPR002919 | |
| Domain | EGF-like_CS | 3.67e-04 | 261 | 191 | 10 | IPR013032 | |
| Domain | EGF_2 | 4.13e-04 | 265 | 191 | 10 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 4.83e-04 | 97 | 191 | 6 | IPR018097 | |
| Domain | PTPc | 4.83e-04 | 36 | 191 | 4 | SM00194 | |
| Domain | EGF_CA | 5.39e-04 | 99 | 191 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 5.68e-04 | 100 | 191 | 6 | PS00010 | |
| Domain | G2F | 6.16e-04 | 4 | 191 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 6.16e-04 | 4 | 191 | 2 | PS50993 | |
| Domain | GFP | 6.16e-04 | 4 | 191 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 6.16e-04 | 4 | 191 | 2 | IPR006605 | |
| Domain | FN3 | 6.47e-04 | 185 | 191 | 8 | SM00060 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.59e-04 | 39 | 191 | 4 | PS50055 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.73e-04 | 106 | 191 | 6 | IPR000152 | |
| Domain | PTPase_domain | 7.98e-04 | 41 | 191 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 7.98e-04 | 41 | 191 | 4 | PF00102 | |
| Domain | VWC_out | 9.04e-04 | 19 | 191 | 3 | SM00215 | |
| Domain | Tyr_Pase_AS | 9.08e-04 | 73 | 191 | 5 | IPR016130 | |
| Domain | Groucho_enhance | 1.02e-03 | 5 | 191 | 2 | IPR009146 | |
| Domain | Protocadherin | 1.02e-03 | 5 | 191 | 2 | PF08374 | |
| Domain | TLE_N | 1.02e-03 | 5 | 191 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 1.02e-03 | 5 | 191 | 2 | IPR005617 | |
| Domain | Protocadherin | 1.02e-03 | 5 | 191 | 2 | IPR013585 | |
| Domain | FN3 | 1.04e-03 | 199 | 191 | 8 | PS50853 | |
| Domain | FN3_dom | 1.42e-03 | 209 | 191 | 8 | IPR003961 | |
| Domain | TYR_PHOSPHATASE_1 | 1.89e-03 | 86 | 191 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 1.99e-03 | 87 | 191 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.99e-03 | 87 | 191 | 5 | PS50056 | |
| Domain | TB | 2.11e-03 | 7 | 191 | 2 | PF00683 | |
| Domain | - | 2.54e-03 | 92 | 191 | 5 | 3.90.190.10 | |
| Domain | VWA | 2.57e-03 | 56 | 191 | 4 | PF00092 | |
| Domain | - | 2.80e-03 | 8 | 191 | 2 | 3.90.290.10 | |
| Domain | V-set | 2.90e-03 | 184 | 191 | 7 | PF07686 | |
| Domain | PTPc_motif | 3.11e-03 | 59 | 191 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.11e-03 | 59 | 191 | 4 | IPR003595 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 4.34e-05 | 20 | 143 | 4 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.31e-05 | 21 | 143 | 4 | M27736 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | CEACAM5 PSG1 PSG3 COL22A1 ITGA1 ITGA5 ADAM8 FBN1 PSG8 COL9A2 EMILIN1 | 6.40e-05 | 258 | 143 | 11 | MM14572 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEXA TANC2 PCSK5 SREBF1 ADGRB2 ITGA5 AHDC1 PHLDB1 PTPRF PTPRS BAHCC1 PITPNM2 HSPG2 FAM89A ESYT1 POLE RTTN POLRMT PAPLN SETD5 BTBD7 TTLL4 TLN1 PCNX1 KLHL17 RASD2 | 1.48e-09 | 1105 | 201 | 26 | 35748872 |
| Pubmed | 1.18e-08 | 14 | 201 | 5 | 18454175 | ||
| Pubmed | 1.18e-08 | 14 | 201 | 5 | 9212243 | ||
| Pubmed | 3.59e-08 | 17 | 201 | 5 | 31676858 | ||
| Pubmed | 5.34e-08 | 167 | 201 | 10 | 22159717 | ||
| Pubmed | Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS. | 6.68e-08 | 19 | 201 | 5 | 19036974 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXA GALNS ARSK SREBF1 RABGAP1 ITGA1 ITGA5 PLD3 LRP1B FBN1 PTPRF PTPRS NAXE MGRN1 HSPG2 ESYT1 RTN4 GPS1 OGFOD3 SELENON MSRB3 SEC24C LRP10 LNPEP | 1.42e-07 | 1201 | 201 | 24 | 35696571 |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.90e-07 | 3 | 201 | 3 | 31985401 | |
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.90e-07 | 3 | 201 | 3 | 33656439 | |
| Pubmed | 1.90e-07 | 3 | 201 | 3 | 9784606 | ||
| Pubmed | 3.46e-07 | 11 | 201 | 4 | 7832766 | ||
| Pubmed | 4.74e-07 | 162 | 201 | 9 | 25826454 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 7.43e-07 | 13 | 201 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 7.43e-07 | 13 | 201 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 7.43e-07 | 13 | 201 | 4 | 16638824 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 20044046 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 32150576 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 6265583 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 7.43e-07 | 13 | 201 | 4 | 12832451 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 7.43e-07 | 13 | 201 | 4 | 21670291 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 22162753 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 2702644 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 8380065 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 1279194 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 25724769 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 7.43e-07 | 13 | 201 | 4 | 22092845 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 11801635 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 7.43e-07 | 13 | 201 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 7.43e-07 | 13 | 201 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 7.43e-07 | 13 | 201 | 4 | 23800882 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 19285068 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 21760897 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 7.43e-07 | 13 | 201 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 7.43e-07 | 13 | 201 | 4 | 39168268 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 8402684 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 16619040 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 7.43e-07 | 13 | 201 | 4 | 8209741 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 7.43e-07 | 13 | 201 | 4 | 21949477 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 26219866 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 2133556 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 32521208 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 19406938 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 7.43e-07 | 13 | 201 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 7.43e-07 | 13 | 201 | 4 | 19358828 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 16680193 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 7.43e-07 | 13 | 201 | 4 | 34058224 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 10964771 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 32169849 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 7.43e-07 | 13 | 201 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 7.43e-07 | 13 | 201 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 7.43e-07 | 13 | 201 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 7.43e-07 | 13 | 201 | 4 | 23935487 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 15331748 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 7.43e-07 | 13 | 201 | 4 | 22406619 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 7.43e-07 | 13 | 201 | 4 | 25972571 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 19008452 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 7.43e-07 | 13 | 201 | 4 | 15220458 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 18843289 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 15207636 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 21081647 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 11133662 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 11483763 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 2164599 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 29396368 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 18003729 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 7.43e-07 | 13 | 201 | 4 | 33352461 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 38381498 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 20739537 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 7.43e-07 | 13 | 201 | 4 | 27695943 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 20404914 | ||
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 7.43e-07 | 13 | 201 | 4 | 32027621 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 7.43e-07 | 13 | 201 | 4 | 27777319 | |
| Pubmed | 7.43e-07 | 13 | 201 | 4 | 18848945 | ||
| Pubmed | 7.57e-07 | 4 | 201 | 3 | 8524829 | ||
| Pubmed | 9.05e-07 | 175 | 201 | 9 | 28071719 | ||
| Pubmed | 1.04e-06 | 14 | 201 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.04e-06 | 14 | 201 | 4 | 34666041 | |
| Pubmed | 1.04e-06 | 14 | 201 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.04e-06 | 14 | 201 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.04e-06 | 14 | 201 | 4 | 32209360 | |
| Pubmed | 1.04e-06 | 14 | 201 | 4 | 11994468 | ||
| Pubmed | 1.04e-06 | 14 | 201 | 4 | 11850617 | ||
| Interaction | SDF2L1 interactions | PCSK5 GALNS PSG1 ARSK VWDE PSG8 LY86 MGRN1 SEMA4D HSPG2 PAPLN VWA1 SELENON LNPEP | 2.55e-06 | 322 | 191 | 14 | int:SDF2L1 |
| Interaction | MRAP2 interactions | 8.45e-06 | 77 | 191 | 7 | int:MRAP2 | |
| Cytoband | 19q13.2 | 8.64e-06 | 164 | 201 | 7 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | CEACAM5 PSG1 PSG3 C5AR2 PLD3 LENG8 ZSWIM9 FCGBP PSG8 NOVA2 LYPD4 GRWD1 GRIK5 LIPE MYBPC2 | 2.68e-04 | 1192 | 201 | 15 | chr19q13 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CEACAM5 LINGO3 HMCN2 PTPRD PTPRF PTPRS HSPG2 PAPLN HMCN1 SIGLEC1 MYBPC2 MYBPC3 | 9.13e-09 | 161 | 149 | 12 | 593 |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.38e-05 | 21 | 149 | 4 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 5.47e-05 | 160 | 149 | 8 | 555 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.62e-05 | 11 | 149 | 3 | 1315 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | PDCD1 CEACAM5 PSG1 ITGA1 ITGA5 TNFRSF17 ADAM8 SEMA4D CR1 SIGLEC1 | 1.61e-03 | 394 | 149 | 10 | 471 |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.83e-03 | 8 | 149 | 2 | 658 | |
| GeneFamily | Fibulins | 1.83e-03 | 8 | 149 | 2 | 556 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.33e-03 | 163 | 149 | 6 | 590 | |
| GeneFamily | Copines | 2.34e-03 | 9 | 149 | 2 | 829 | |
| GeneFamily | Non-clustered protocadherins | 4.22e-03 | 12 | 149 | 2 | 21 | |
| GeneFamily | Low density lipoprotein receptors | 4.96e-03 | 13 | 149 | 2 | 634 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.07e-03 | 134 | 149 | 5 | 861 | |
| Coexpression | NABA_CORE_MATRISOME | COL22A1 VWDE FBN1 HMCN2 HSPG2 COL9A2 PAPLN VWA1 EMILIN1 HMCN1 VWA5A FBN3 | 1.41e-06 | 275 | 199 | 12 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL22A1 VWDE FBN1 HMCN2 HSPG2 COL9A2 PAPLN VWA1 EMILIN1 HMCN1 VWA5A | 7.52e-06 | 270 | 199 | 11 | MM17057 |
| Coexpression | GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN | 1.93e-05 | 195 | 199 | 9 | M8142 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.01e-05 | 196 | 199 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME | TPO PCSK5 COL22A1 ADAM8 VWDE FBN1 HMCN2 SEMA4D HSPG2 COL9A2 PAPLN VWA1 CPN2 EMILIN1 HMCN1 VWA5A BRINP2 MUC2 MUC6 FBN3 IL26 | 3.83e-05 | 1026 | 199 | 21 | M5889 |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 4.23e-05 | 26 | 199 | 4 | M16488 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 DRGX BRINP1 RABGAP1 ITGA5 SOCS7 USP31 PTPRF ANAPC1 PTPRS GLI3 PCDH11X MGRN1 CPEB2 APC RGS4 MSRB3 TBX18 SETD5 LNPEP TLE3 | 1.48e-05 | 818 | 190 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 LRP1B PTPRD PCDH11X STAB2 ANK1 DNAH10 PKHD1L1 HMCN1 | 1.23e-08 | 184 | 201 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 LRP1B PTPRD PCDH11X STAB2 ANK1 DNAH10 PKHD1L1 HMCN1 | 1.23e-08 | 184 | 201 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 COL22A1 LRP1B PTPRD PCDH11X STAB2 ANK1 DNAH10 PKHD1L1 HMCN1 | 1.23e-08 | 184 | 201 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 9.75e-08 | 173 | 201 | 9 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.89e-07 | 187 | 201 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-07 | 161 | 201 | 8 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 9.96e-07 | 168 | 201 | 8 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-06 | 174 | 201 | 8 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-06 | 176 | 201 | 8 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 1.54e-06 | 178 | 201 | 8 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.55e-06 | 124 | 201 | 7 | 57f3335f751868a768934c757b06a6378148dc9e | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-06 | 179 | 201 | 8 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-06 | 127 | 201 | 7 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-06 | 188 | 201 | 8 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-06 | 188 | 201 | 8 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | 15-Trachea-Endothelial-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.81e-06 | 193 | 201 | 8 | 6ea0444fc3dc156997129387184e6418947f4b12 | |
| ToppCell | 15-Trachea-Endothelial|Trachea / Age, Tissue, Lineage and Cell class | 2.81e-06 | 193 | 201 | 8 | b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.81e-06 | 193 | 201 | 8 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.81e-06 | 193 | 201 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.81e-06 | 193 | 201 | 8 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 201 | 8 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.92e-06 | 194 | 201 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-06 | 195 | 201 | 8 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 195 | 201 | 8 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 196 | 201 | 8 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.52e-06 | 199 | 201 | 8 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 199 | 201 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-06 | 199 | 201 | 8 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 200 | 201 | 8 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-06 | 155 | 201 | 7 | 98d8432739965dd1ab77c899cb6321f7f05eaa46 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-06 | 163 | 201 | 7 | 00e791358a7eb6c3e95f87afe22153845012e4a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 172 | 201 | 7 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.34e-05 | 172 | 201 | 7 | 9a659442dc41bd2a4361a7e38a7ee37a39781667 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-05 | 174 | 201 | 7 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 175 | 201 | 7 | 5552ff1e13f931c8cd7780726c90b5609497a648 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.56e-05 | 176 | 201 | 7 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 178 | 201 | 7 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.67e-05 | 178 | 201 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.80e-05 | 180 | 201 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-05 | 181 | 201 | 7 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 181 | 201 | 7 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-05 | 181 | 201 | 7 | 338c7362d258a87f1a6b1a65376f5394d4b2b4b2 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 181 | 201 | 7 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.00e-05 | 183 | 201 | 7 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.00e-05 | 183 | 201 | 7 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.07e-05 | 184 | 201 | 7 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 185 | 201 | 7 | 4cfef50aeed5b3000ce5e864a41c13740b8267b1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 185 | 201 | 7 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 185 | 201 | 7 | c3105978d971da7d0fad1a717ee29afee5ed6357 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-05 | 185 | 201 | 7 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 185 | 201 | 7 | 09256c6f42f59b7eb89160b2ea706172a5b743be | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.22e-05 | 186 | 201 | 7 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 2.30e-05 | 187 | 201 | 7 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 2.38e-05 | 188 | 201 | 7 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 188 | 201 | 7 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 188 | 201 | 7 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-05 | 188 | 201 | 7 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 188 | 201 | 7 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.38e-05 | 188 | 201 | 7 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.43e-05 | 127 | 201 | 6 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 189 | 201 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-05 | 189 | 201 | 7 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-05 | 189 | 201 | 7 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 190 | 201 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 190 | 201 | 7 | 6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.55e-05 | 190 | 201 | 7 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 190 | 201 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 190 | 201 | 7 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 190 | 201 | 7 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.55e-05 | 190 | 201 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 190 | 201 | 7 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 191 | 201 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.63e-05 | 191 | 201 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 191 | 201 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 192 | 201 | 7 | 5890076929598e88fe9d59a4e4e858b446746ce9 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 192 | 201 | 7 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 192 | 201 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 192 | 201 | 7 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 192 | 201 | 7 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 193 | 201 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 193 | 201 | 7 | d5f6d6e2c36d4e80af4d39cdfc0b18df295a587b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 193 | 201 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 193 | 201 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.81e-05 | 193 | 201 | 7 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-05 | 193 | 201 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.81e-05 | 193 | 201 | 7 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-05 | 193 | 201 | 7 | 4a8c97ff2dffc5c06351d1cb107e21e58250aa55 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.81e-05 | 193 | 201 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.90e-05 | 131 | 201 | 6 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 194 | 201 | 7 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-05 | 194 | 201 | 7 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-05 | 194 | 201 | 7 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.91e-05 | 194 | 201 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.91e-05 | 194 | 201 | 7 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-05 | 194 | 201 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | SREBF1 DENND2B PHLDB1 ALMS1 HPS4 C1orf159 LTB4R NOVA2 GRIK5 TEX14 TLE3 | 1.30e-06 | 200 | 195 | 11 | 3322_UP |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | BCL6 ADAM8 FBN1 PTPRB PTPRS FBXO41 NOVA2 TFAP2B TTLL4 SORCS3 | 7.42e-06 | 195 | 195 | 10 | 6039_UP |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | PPP1R12B FBXO41 C1orf159 GRWD1 APC RIN1 PRKAA2 ZFHX2 PCNX1 DUSP10 | 7.42e-06 | 195 | 195 | 10 | 7400_DN |
| Drug | Delcorine; Up 200; 8.4uM; PC3; HT_HG-U133A | 7.76e-06 | 196 | 195 | 10 | 4275_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | GALNS DHRS3 RABGAP1 ZFYVE9 FBXO41 BAHCC1 SEMA4D GRWD1 APC TLN1 | 7.76e-06 | 196 | 195 | 10 | 1156_DN |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | CEACAM5 C1orf159 LTB4R NOVA2 HSPG2 RIN1 VWA5A ZFHX2 PCNX1 ATP2A1 | 8.48e-06 | 198 | 195 | 10 | 4142_UP |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 8.87e-06 | 199 | 195 | 10 | 2807_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 8.87e-06 | 199 | 195 | 10 | 4423_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.24e-05 | 185 | 195 | 9 | 4445_UP | |
| Drug | Rgd Peptide | 4.29e-05 | 239 | 195 | 10 | CID000104802 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 4.51e-05 | 193 | 195 | 9 | 4253_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 4.88e-05 | 195 | 195 | 9 | 5608_UP | |
| Drug | Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 195 | 9 | 4409_UP | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A | 5.08e-05 | 196 | 195 | 9 | 1904_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 195 | 9 | 2862_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 5.29e-05 | 197 | 195 | 9 | 6099_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; HL60; HT_HG-U133A | 5.29e-05 | 197 | 195 | 9 | 3004_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; PC3; HT_HG-U133A | 5.29e-05 | 197 | 195 | 9 | 3983_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 5.50e-05 | 198 | 195 | 9 | 2772_UP | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; MCF7; HG-U133A | 5.50e-05 | 198 | 195 | 9 | 202_DN | |
| Drug | Repaglinide [135062-02-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 5.50e-05 | 198 | 195 | 9 | 5862_UP | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A | 5.50e-05 | 198 | 195 | 9 | 3131_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 5.50e-05 | 198 | 195 | 9 | 2791_UP | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 5.72e-05 | 199 | 195 | 9 | 3287_UP | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | 5.72e-05 | 199 | 195 | 9 | 4064_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 5.72e-05 | 199 | 195 | 9 | 6491_DN | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 4.12e-05 | 2 | 190 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | lipid storage disease (biomarker_via_orthology) | 4.12e-05 | 2 | 190 | 2 | DOID:9455 (biomarker_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 5.20e-05 | 32 | 190 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA4 STARD8 GALNS BRINP1 PTPRD PTPRS GLI3 PCDH11X OR1E2 DLG3 POLE RTN4 APC DCHS1 DHRS2 | 5.41e-05 | 702 | 190 | 15 | C0009402 |
| Disease | heart disease (implicated_via_orthology) | 1.04e-04 | 38 | 190 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | decreased susceptibility to hepatitis C infection | 1.38e-04 | 16 | 190 | 3 | EFO_0010101 | |
| Disease | Disproportionate short stature | 1.43e-04 | 77 | 190 | 5 | C0878659 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.76e-04 | 20 | 190 | 3 | C0026760 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 4.07e-04 | 5 | 190 | 2 | DOID:3030 (is_marker_for) | |
| Disease | thioredoxin domain-containing protein 5 measurement | 6.08e-04 | 6 | 190 | 2 | EFO_0802128 | |
| Disease | Bone Diseases, Developmental | 6.86e-04 | 27 | 190 | 3 | C0005941 | |
| Disease | azoospermia (implicated_via_orthology) | 6.86e-04 | 27 | 190 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Stomach Neoplasms | 7.17e-04 | 297 | 190 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 7.66e-04 | 300 | 190 | 8 | C0024623 | |
| Disease | Rectal Neoplasms | 8.48e-04 | 7 | 190 | 2 | C0034885 | |
| Disease | Rectal Carcinoma | 8.48e-04 | 7 | 190 | 2 | C0007113 | |
| Disease | lymphocyte measurement | 9.83e-04 | 117 | 190 | 5 | EFO_0803546 | |
| Disease | sarcoma (is_implicated_in) | 1.13e-03 | 8 | 190 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | ovarian cancer (implicated_via_orthology) | 1.13e-03 | 8 | 190 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 1.16e-03 | 71 | 190 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | visceral adipose tissue measurement | ADGRB2 COL22A1 TTC34 SEMA4D DNAH10 TFAP2B SEC24C TLE1 SIGLEC1 CPNE4 | 1.18e-03 | 481 | 190 | 10 | EFO_0004765 |
| Disease | mitral valve prolapse (is_implicated_in) | 1.44e-03 | 9 | 190 | 2 | DOID:988 (is_implicated_in) | |
| Disease | multiple sclerosis | BRINP1 BCL6 TTC34 USP31 GARIN3 PHLDB1 ESPN PITPNM2 MEF2B NDFIP1 MYBPC3 | 1.71e-03 | 594 | 190 | 11 | MONDO_0005301 |
| Disease | orofacial cleft | 1.74e-03 | 37 | 190 | 3 | MONDO_0000358 | |
| Disease | decadienedioic acid (C10:2-DC) measurement | 1.79e-03 | 10 | 190 | 2 | EFO_0800598 | |
| Disease | 2-ketocaprylate measurement | 1.79e-03 | 10 | 190 | 2 | EFO_0800110 | |
| Disease | intraocular pressure measurement | PCSK5 ABCA4 ADGRB2 NEDD4 FBN1 ANAPC1 ARID5B ARHGAP20 TCF12 MYBPC3 | 1.80e-03 | 509 | 190 | 10 | EFO_0004695 |
| Disease | dentate gyrus volume measurement | 2.03e-03 | 39 | 190 | 3 | EFO_0010083 | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.61e-03 | 12 | 190 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | N-delta-acetylornithine measurement | 2.61e-03 | 12 | 190 | 2 | EFO_0800067 | |
| Disease | Intestinal Neoplasms | 2.61e-03 | 12 | 190 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 2.61e-03 | 12 | 190 | 2 | C0346627 | |
| Disease | obesity (implicated_via_orthology) | 2.78e-03 | 215 | 190 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 3.01e-03 | 293 | 190 | 7 | C1708349 | |
| Disease | platelet aggregation | 3.06e-03 | 45 | 190 | 3 | GO_0070527 | |
| Disease | Congenital Hypothyroidism | 3.07e-03 | 13 | 190 | 2 | C0010308 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.07e-03 | 13 | 190 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | multiple sclerosis symptom measurement | 3.25e-03 | 46 | 190 | 3 | EFO_0803536 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 3.57e-03 | 14 | 190 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 15:0 measurement | 3.57e-03 | 14 | 190 | 2 | EFO_0020941 | |
| Disease | unipolar depression, anxiety | 3.57e-03 | 14 | 190 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.89e-03 | 49 | 190 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis, age at onset | 4.10e-03 | 15 | 190 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | 1,3,7-trimethylurate measurement | 4.10e-03 | 15 | 190 | 2 | EFO_0021172 | |
| Disease | non-dense area measurement, mammographic density measurement | 4.10e-03 | 15 | 190 | 2 | EFO_0005941, EFO_0006504 | |
| Disease | response to fenofibrate | 4.12e-03 | 50 | 190 | 3 | GO_1901557 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.36e-03 | 51 | 190 | 3 | cv:CN043650 | |
| Disease | Orofacial cleft | 4.36e-03 | 51 | 190 | 3 | HP_0000202 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.66e-03 | 16 | 190 | 2 | C0038015 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 4.66e-03 | 16 | 190 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.66e-03 | 16 | 190 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.66e-03 | 16 | 190 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 4.66e-03 | 16 | 190 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.66e-03 | 16 | 190 | 2 | C0025237 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.86e-03 | 53 | 190 | 3 | C4707243 | |
| Disease | Benign neoplasm of stomach | 5.26e-03 | 17 | 190 | 2 | C0153943 | |
| Disease | response to radiation, Urinary retention | 5.26e-03 | 17 | 190 | 2 | GO_0009314, HP_0000016 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.26e-03 | 17 | 190 | 2 | C0496905 | |
| Disease | Astrocytosis | 5.26e-03 | 17 | 190 | 2 | C3887640 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 5.26e-03 | 17 | 190 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 5.26e-03 | 17 | 190 | 2 | C0154060 | |
| Disease | Van Buchem disease | 5.26e-03 | 17 | 190 | 2 | C0432272 | |
| Disease | Gliosis | 5.26e-03 | 17 | 190 | 2 | C0017639 | |
| Disease | cognitive function measurement | TANC2 BRINP1 LRP1B PTPRD ALMS1 PTPRF GLI3 HES7 SEMA4D HEATR4 TEX14 TFAP2B NDFIP1 SORCS3 MUC2 CPNE7 MYBPC2 MYBPC3 | 5.39e-03 | 1434 | 190 | 18 | EFO_0008354 |
| Disease | factor VII activating protease measurement | 5.39e-03 | 55 | 190 | 3 | EFO_0009368 | |
| Disease | lower face morphology measurement | 5.48e-03 | 109 | 190 | 4 | EFO_0010948 | |
| Disease | blood phosphate measurement | 5.49e-03 | 174 | 190 | 5 | EFO_0010972 | |
| Disease | Age-related macular degeneration | 5.90e-03 | 18 | 190 | 2 | cv:C0242383 | |
| Disease | Malignant neoplasm of endometrium | 5.90e-03 | 18 | 190 | 2 | C0007103 | |
| Disease | cD177 antigen measurement | 5.90e-03 | 18 | 190 | 2 | EFO_0021866 | |
| Disease | Tourette syndrome, schizophrenia | 5.90e-03 | 18 | 190 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Carcinoma in situ of endometrium | 5.90e-03 | 18 | 190 | 2 | C0346191 | |
| Disease | waist-hip ratio | PCSK5 BCL6 PTPRD PTPRS GLI3 ARID5B LY86 DNAH10 TFAP2B NDFIP1 MSRB3 TBX18 SLC7A2 PCNX1 CPNE4 ATP2A1 | 5.98e-03 | 1226 | 190 | 16 | EFO_0004343 |
| Disease | endometrial carcinoma | 6.22e-03 | 113 | 190 | 4 | EFO_1001512 | |
| Disease | urate measurement, spine bone mineral density | 6.25e-03 | 58 | 190 | 3 | EFO_0004531, EFO_0007701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AADYCIPSFLGSTVQ | 351 | Q8N1M1 | |
| APSACSALASGVLYG | 36 | O60241 | |
| RGTSFLNAYTNSPIC | 66 | Q6UWY0 | |
| SDPYALVRLGTQTFC | 356 | Q9BSJ8 | |
| SGYFELPTSSQDCAR | 491 | Q9P281 | |
| AARSQCTYSNPEGTV | 476 | P22792 | |
| STVFQCDPGYALQGS | 1406 | Q7Z408 | |
| DVPSTAYVALSCANL | 1786 | P78363 | |
| PLGCNSYDNLDSVSS | 201 | O60477 | |
| DGEFLRTSCGSPNYA | 166 | P54646 | |
| SLGCALSSPLRADQY | 1526 | P16157 | |
| PDSSYLSGANLNLSC | 601 | P06731 | |
| GFNYISNTSSDCRPS | 3726 | Q8TCU4 | |
| SPSVSGELACYNNAI | 1191 | Q8IYW2 | |
| AASYGLTPAASDCRA | 926 | Q5TGY3 | |
| VEGYPDSAASLSTCA | 111 | P78325 | |
| QAGYTPDATATTCLD | 2391 | Q75N90 | |
| TASFGYLDRSPSACK | 96 | P78524 | |
| PAKYVVAAGSLCALS | 336 | P52569 | |
| GDSYLSCQQPAALSQ | 66 | Q92988 | |
| VYCSPAKSSRAAVGN | 496 | O14983 | |
| GAPAICAALTALQNY | 406 | Q92481 | |
| AEGTLCASPNSTAVY | 456 | Q5T481 | |
| TTADAGFYLCVATSP | 2016 | P98160 | |
| ASPADAGQYVCRASN | 2301 | P98160 | |
| INLDCTNPRYLAAGS | 176 | Q5HYI8 | |
| TSNSSIAALLCALYP | 1576 | Q9H1A4 | |
| GRILFGDSCYPSNDS | 426 | Q9UM07 | |
| TYLGCASVNAPRSEV | 151 | Q9Y3P9 | |
| CGALLSAGLANTSYT | 11 | Q6W4X9 | |
| QCPSYTFSVSAVDGA | 1921 | Q96JQ0 | |
| ICLNGTPALAYLASA | 281 | Q8IV08 | |
| RILGSPCNFSLIYSS | 46 | P23467 | |
| GTRYAITIAFSCNPD | 296 | Q6PK18 | |
| CIYLQPRSSEAGAGA | 271 | Q8NGN2 | |
| APTNASNCTDALAYS | 6 | P35372 | |
| GSLASLECYVPSTNQ | 431 | Q9H511 | |
| LAGLSCATAIAKAYP | 86 | Q8NCW5 | |
| SLAVVRGYQPCASFG | 1376 | P10071 | |
| AGTSGATACYLPADR | 366 | Q7Z4F1 | |
| PTNFYLAADNRTCLS | 3301 | Q9NZR2 | |
| SISLGGAYPNISCLS | 456 | P46934 | |
| GSSVLNFSYPICEAA | 91 | O95711 | |
| LALGTAASYPRACQA | 281 | Q8IXH7 | |
| LYHRAQTGAPCLSFD | 56 | Q9BQ67 | |
| ICSPLSGANEYIAST | 821 | Q96S38 | |
| YGNLAPSTEAGQVFC | 111 | Q96T55 | |
| CVASSPAGEAVLQYS | 1696 | Q8NDA2 | |
| DAGLYTCLAESPAGA | 3566 | Q8NDA2 | |
| GPFASRSLSDCVNYI | 396 | O15111 | |
| ASGICTLLYDSAPSG | 1181 | P46020 | |
| ASNIASCSGPLYLAA | 166 | Q8WXK4 | |
| YSGISDGLSQASCPL | 416 | O60291 | |
| LGLAYTGPDNSSIDC | 776 | Q96PV6 | |
| PCGLSSARAADIQSY | 396 | B1AK53 | |
| DGRAPYCKASLSASS | 396 | Q9NQG7 | |
| CLDSSYLGSANPGSN | 26 | Q9Y6W6 | |
| GCSSRNSYAGLDPSN | 141 | Q96RV3 | |
| PNSAVRSIYKASGCS | 481 | Q92824 | |
| RYVAAAFPSACGKTN | 296 | Q16822 | |
| NDSGTYLCGAISLAP | 116 | Q15116 | |
| LLSAPQSYLSCGNIS | 181 | Q9H342 | |
| GSSLECASLQAYAAL | 4726 | Q02817 | |
| AAGTACLPFYRSSAA | 281 | P07202 | |
| PSNVAIYGGLCALAT | 286 | Q13098 | |
| SFSLYSRDTGLPGCQ | 116 | Q99081 | |
| RPQDSGTYTCVASNA | 471 | P0C6S8 | |
| SATGYRQSPDGACSV | 91 | Q9UIQ6 | |
| LPRAGALLCYEATAS | 21 | Q6UWN0 | |
| FINSADPVGSCSSYE | 121 | A8MYU2 | |
| ECGRYASFNAIPSLA | 66 | Q86WI0 | |
| GGPRALATLCFQASY | 456 | Q2VPB7 | |
| ASAPASYDETALCSN | 1776 | Q07864 | |
| SALCYSPPLAQAAAI | 1241 | Q9BZA7 | |
| VCSDAFALVSNLSPY | 481 | Q9BZ72 | |
| VLYPTGLSSSENANC | 1016 | P56199 | |
| SSSCLNISYANVAGP | 206 | Q9UNW9 | |
| RYAICSALAASALPA | 121 | P36578 | |
| SASPADRGVLTTCYN | 71 | Q53HC9 | |
| RSLYSGLQNPCSTAT | 226 | Q02080 | |
| LSSSVNPVLYACAGG | 276 | Q15722 | |
| PASSGSGCLRSLFYL | 31 | Q8N4S7 | |
| ATPSDAGIYTCVATN | 1231 | Q96RW7 | |
| CVATNSAGVRYSSPA | 216 | Q13332 | |
| LVRHPGNFSSLSCDY | 706 | P08648 | |
| AALAAVEPACGSRYQ | 6 | Q9BT67 | |
| NFYSANPLCSPSRAA | 71 | P34059 | |
| ACDLATDPGFQAYSN | 896 | Q9BYE9 | |
| GASCLNSAERYDPLT | 446 | Q6TDP4 | |
| SDQVGVLNSPTCYSA | 306 | Q7Z5Q1 | |
| PARLQCVVDYGGSSS | 181 | Q9P296 | |
| NYSCNEGFRLIGSPS | 1481 | P17927 | |
| QSGPLCDALATYAAA | 1101 | Q9Y6R7 | |
| AQNSAEYQALCSSGP | 701 | P35555 | |
| IYRPAADNSASSLCA | 11 | Q5K131 | |
| ASNGDPRNSCSLHYI | 316 | Q96A23 | |
| ASNGDPRNSCSLHYI | 391 | Q9UBL6 | |
| PAACLGASAYASARL | 666 | Q14055 | |
| AAAQCLALEGTATYP | 581 | Q86WZ0 | |
| SCYPRGTLSQAVDAL | 31 | Q9NPH9 | |
| DPSQCAYFASLAARP | 1606 | Q8NFW1 | |
| RDSCLPSQGLSFSYG | 516 | Q92796 | |
| LYSNVACPGTALTNL | 216 | P56937 | |
| YDFSNAACRPSTPAL | 946 | Q9P203 | |
| SAPGCESRAFAPSLY | 171 | P41182 | |
| SFLPTYGCQSNRTAS | 191 | A6NNA5 | |
| HYSALSSLARACPEG | 31 | Q8N2R8 | |
| RVPAASQSSGCYDSD | 406 | Q8TF61 | |
| YPGRSLVFANSISCI | 586 | Q9GZR7 | |
| LCCLLTAAAGAASYP | 11 | Q9Y6C2 | |
| NNESTLPYDLACTGG | 391 | Q6PJP8 | |
| NCEASTYLGPALSAA | 291 | Q16478 | |
| PVQDAEALASCYLSG | 81 | Q9BYE0 | |
| TLPAYNGSECRSFAG | 106 | Q96HA4 | |
| SFLCSPDASYVNGEN | 256 | Q13268 | |
| VGDLQYASPATVSRC | 2231 | Q8IVF4 | |
| CYRKNCASPSSAGQL | 881 | P53992 | |
| GLTPDLLSYAAALQC | 291 | O00411 | |
| SSGAVSCPYASAAAA | 231 | O75364 | |
| AIPGAIDYCTSKASA | 181 | O75911 | |
| SGEVLYLSCSADSNP | 346 | P11464 | |
| SCRVPSLAGAAGYIS | 36 | O76013 | |
| PLSVLSKCVSAYAGA | 776 | Q05469 | |
| PCFNRSTYAQGTTVA | 376 | Q8WUT4 | |
| ECVATNSAGTRYSAP | 206 | P10586 | |
| GLYLCPSANSSTLKD | 266 | P47887 | |
| AQASALCYSPPLAQA | 1231 | Q9BZA8 | |
| SGENLYLSCFADSNP | 346 | Q16557 | |
| ECVATNSAGTRYSAP | 206 | P23468 | |
| FQYDVSSAAQPGCSV | 46 | P06865 | |
| LSCDAASQAGSNYPR | 26 | Q8IWL3 | |
| GLYKPCDVSAATSSA | 216 | Q8TC56 | |
| CTPSYLSTAAANAAK | 681 | Q9P2F6 | |
| DRSGAYITCAPFNPA | 456 | Q9NQC3 | |
| AGLSATCPALYTASL | 1781 | Q86VV8 | |
| AYQDPSSGCTSKTLA | 631 | Q13671 | |
| RPSAPSLCYFVAGAS | 56 | Q7Z7N9 | |
| PGSVSSAASQYKDCL | 1216 | Q8IWB6 | |
| CTGARPANPSAYAAA | 266 | O00358 | |
| QDSLDRSYSTPSGCL | 506 | P0DPF2 | |
| LQDSLDRSYSTPSGC | 1481 | P0DPF2 | |
| QDSLDRSYSTPSGCL | 1726 | P0DPF2 | |
| LQDSLDRSYSTPSGC | 2701 | P0DPF2 | |
| QDSLDRSYSTPSGCL | 2946 | P0DPF2 | |
| SRFYLDLVNPSSCGA | 171 | P49798 | |
| SPSKDCSLGQSYLNS | 776 | Q9UPU3 | |
| QAASSPDCTYALENG | 126 | Q96GI7 | |
| LSIYCRPSSGNSGDA | 256 | Q8NGL2 | |
| SGEVLYLSCSADSNP | 346 | Q9UQ74 | |
| GYLDSNTNSCADRPS | 921 | Q9C0A6 | |
| GDNLTISASCYTPRA | 246 | Q9NY91 | |
| NATAKDCSYGAVTSP | 156 | Q9HCD6 | |
| QPLSATSLYVCGTNA | 116 | Q92854 | |
| RYCINSAALSFTPAD | 156 | Q8IXL7 | |
| CAANGTLSPEGRVAY | 961 | Q7RTU9 | |
| QLCSSYSAAELSPPG | 786 | Q92502 | |
| SAYGIQCPAILAALA | 176 | Q96BI1 | |
| QLLNSCSDAAGAPAY | 841 | P36956 | |
| PLGCSNYDNLDSVSS | 231 | Q9C0B6 | |
| PFSTCRVTQTYDAGA | 561 | O00116 | |
| LCNSGLNSRLPAGYS | 1086 | Q14865 | |
| GTPYCFSRNDSLSSL | 1851 | P25054 | |
| NCTTLQGLAPGTAYL | 386 | Q6PCB0 | |
| SDRNFSPGSGVYLCV | 1191 | Q8N2E2 | |
| GLESAAPSQTSVYFC | 96 | A0A0J9YXY3 | |
| TSSAPACYALAISPD | 571 | Q04724 | |
| YSIGTNNTAPLAICS | 466 | Q6AZZ1 | |
| LCRLAGASSPAAYDE | 346 | Q86XI8 | |
| PEGAIVSLNCTYSNS | 36 | A0A0B4J271 | |
| SSEGLLAAQRTDCPY | 2136 | Q9C0A1 | |
| TCYPVAGTFDANDLS | 181 | O95428 | |
| GLESAAPSQTSVYFC | 96 | P0DPF7 | |
| SLAPADYSACARSGL | 411 | O95935 | |
| VTKAGALQCSPSDAY | 1931 | Q9Y490 | |
| SQTFCGSTAYAAPEV | 166 | Q96PN8 | |
| EAYRSLASAQCPFLG | 351 | O43791 | |
| PQGAVACLTAISDFY | 271 | Q9NZV5 | |
| ASYFLSRAQSLCGPE | 736 | Q12772 | |
| SSGNCTLSVPAKNSY | 6 | Q96D21 | |
| TGRVAYPTAFASQNC | 2251 | Q8WWQ8 | |
| PRYQFSGSSKDSCLN | 151 | O00534 | |
| LLPAASSTDAGSYHC | 561 | Q9BZZ2 | |
| EGFYSCSARSPLGQA | 1236 | Q9BZZ2 | |
| ATARDAFSYNCLQTP | 1226 | Q86WI1 | |
| AYSLGSLTGASPCQS | 541 | Q86UU1 | |
| LQCPLYRPDSSSFAA | 376 | O14512 | |
| ELTSSAPACYALAIS | 571 | Q04726 | |
| AYPCAVGQTAFSSGR | 336 | Q9Y577 | |
| DPSALTQAVAAYQGC | 551 | Q96S55 | |
| GNSCANPFLYTLLTR | 306 | Q9UKP6 | |
| GSIDCQYPGSALALD | 111 | Q14694 | |
| CLNSYSDNSRFPLAV | 736 | Q9Y2L5 | |
| CAANGTLSPEGRVAY | 961 | A6NGW2 | |
| LSPEAQARYCLTSFA | 271 | O75800 | |
| CFGSLRNLSSSYQEP | 911 | Q70CQ4 | |
| SSSTEPYLCLAAAGE | 176 | Q14679 | |
| TNDYCKSLPAALSAT | 161 | Q02223 | |
| IAASQPGDSATYLCA | 96 | A0A0B4J279 | |
| PRQALGYCSLSVLAS | 406 | A8MYJ7 | |
| CGSAAYAAPEVLQSI | 176 | Q96PF2 | |
| IGYASALVSLLNPCA | 626 | Q9HBA0 | |
| IDTPAANYLSNGCDS | 466 | O95405 | |
| FLPTAAAYTCVSRLG | 16 | Q13488 | |
| YNECFSRATSIFPSG | 461 | Q13488 | |
| DCGRNFSYPSLLASH | 176 | A8K8V0 | |
| TTSLCAGPSASKNEY | 726 | Q9BWU0 | |
| SPFDAGTYTCRAVNE | 1111 | Q14324 | |
| ITDAQPAFTGSYRCE | 226 | Q14896 | |
| TPLHAAASCGYLNIA | 126 | O60237 |